ScoreWhy is Bliss GVS Pharma Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 9.41% and Operating profit at 1.49% over the last 5 years
3
Flat results in Sep 25
- INTEREST(9M) At Rs 10.19 cr has Grown at 58.23%
- PBT LESS OI(Q) At Rs 20.45 cr has Fallen at -33.32%
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.75 times
4
With ROE of 9.7, it has a Attractive valuation with a 1.4 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.95%, its profits have risen by 18.4% ; the PEG ratio of the company is 0.8
5
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.53% over the previous quarter and collectively hold 19.2% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bliss GVS Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bliss GVS Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bliss GVS Pharma
94.28%
0.04
54.90%
Sensex
-4.3%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.97%
EBIT Growth (5y)
3.85%
EBIT to Interest (avg)
13.29
Debt to EBITDA (avg)
0.78
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.73
Tax Ratio
31.95%
Dividend Payout Ratio
6.25%
Pledged Shares
0
Institutional Holding
20.33%
ROCE (avg)
12.28%
ROE (avg)
9.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
31
Price to Book Value
2.19
EV to EBIT
21.65
EV to EBITDA
16.59
EV to Capital Employed
2.37
EV to Sales
2.69
PEG Ratio
0.93
Dividend Yield
0.43%
ROCE (Latest)
10.53%
ROE (Latest)
9.68%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
ROCE(HY)
Highest at 14.76%
DEBT-EQUITY RATIO(HY)
Lowest at 0.05 times
PAT(9M)
Higher at Rs 95.08 Cr
-6What is not working for the Company
INTEREST(9M)
At Rs 10.00 cr has Grown at 51.75%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.75 times
NON-OPERATING INCOME(Q)
is 42.52 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Bliss GVS Pharma
Debt-Equity Ratio - Half Yearly
Lowest at 0.05 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Profit After Tax (PAT) - Nine Monthly
At Rs 95.08 cr has Grown at 38.28%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 95.08 Cr
than preceding 12 month period ended Dec 2025 of Rs 84.30 crMOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Bliss GVS Pharma
Interest - Nine Monthly
At Rs 10.00 cr has Grown at 51.75%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 1.75 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
is 42.52 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
